SPHK1 and non-small cell lung carcinoma: Increased SphK1 expression in NSCLC was associated with poorer survival in patients receiving platinum-based chemotherapy; there is a strong positive association between SphK1 levels and more advanced disease (Gachechiladze et al., 2019).